ArticleJournal of radiation research2026

Mid-treatment MRI-based tumor volume reduction rate as a continuous prognostic factor after chemoradiation for cervical cancer: development and two-center internal-external validation.

Takashi Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.